STOCKHOLDERS’ EQUITY (Details Narrative) - USD ($)	12 Months Ended
	Oct. 31, 2020	Oct. 31, 2019	Jan. 31, 2020
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Number of treasury stock shares	0	0
Stock options granted		1,000,000
Stock options purchase price per share		$ 5.43
Stock-based compensation	$ 868,477	$ 476,899
Unrecognized stock compensation expense	$ 1,164,894
Board of Directors [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Share-based compensation, options, number of shares authorized			1,000,000
Five Board Members [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Stock options granted		59,000
Stock options purchase price per share		$ 5.43
Stock options expected term		six years
Stock options vesting period		12 months
Stock options aggregate grant date fair value		$ 233,050
Officers and Employees [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Stock options granted		941,000
Stock options purchase price per share		$ 5.43
Stock options expected term		six years
Stock options vesting period		3 years
Stock options aggregate grant date fair value		$ 2,277,220